Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Intangibles (2025 - 2026)

Maxcyte has reported Intangibles over the past 1 years, most recently at $650000.0 for Q4 2025.

  • Quarterly Intangibles changed N/A to $650000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $650000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $650000.0 for FY2025, N/A changed from the prior year.
  • Intangibles was $650000.0 for Q4 2025 at Maxcyte, down from $667000.0 in the prior quarter.
  • Over five years, Intangibles peaked at $667000.0 in Q3 2025 and troughed at $498000.0 in Q1 2025.